See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420030_2012_Targeted_Medical_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420030, Targeted Medical Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,899,717 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,387,801 |
| 2 | PropertyPlantAndEquipmentNet | 411,823 |
| 3 | remainder_Assets | 3,089,116 |
| 4 | LiabilitiesCurrent | 7,585,172 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 988,980 |
| 7 | CostOfGoodsAndServicesSold | 2,757,033 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,670,092 |
| 9 | ResearchAndDevelopmentExpense | 163,081 |
| 10 | remainder_Expenses | -2,471,630 |
| 11 | remainder_Revenues | 8,809,668 |
| 12 | remainder_NetIncome | -868,142 |
| 13 | remainder_ComprehensiveNetIncome | -3,209 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,788,457 |
| 1 | Liabilities | 8,574,152 |
| 2 | Expenses | 12,118,576 |
| 3 | Revenues | 8,809,668 |
| 4 | StockholdersEquity | 214,305 |
| 5 | NetIncome | -4,177,050 |
| 6 | ComprehensiveNetIncome | -4,178,654 |
| 7 | BaseVar | 19,581,102 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.428 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
